Literature DB >> 1354292

Asystole and cardiogenic shock due to combined treatment with verapamil and flecainide.

J Buss, J J Lasserre, D L Heene.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354292     DOI: 10.1016/0140-6736(92)91740-y

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Fatal cardiogenic shock and liver failure induced by verapamil in a thyrotoxic patient.

Authors:  Leon Margolin
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 2.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 3.  Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.

Authors:  R N Brogden; P Benfield
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.